Early diagnosis of Hantavirus infection by family doctors can reduce inappropriate antibiotic use and hospitalization

References

• Centers for Disease Control and Prevention. Hantavirus pulmonary syndrome—United States: Updated recommendations for risk reduction. MMWR 2002;51:1–12.
   Google Scholar
• Graziano KL, Tempest B. Hantavirus pulmonary syndrome: A zebra worth knowing. Am Fam Physician 2002; 66:1015–20.
   PubMedGoogle Scholar
• Pierce JR Jr, Milton JS. Is Hantavirus important to practitioners? South Med J 2009;102:563–4.
   PubMedGoogle Scholar
• Kariwa H, Yoshimatsu K, Arikawa J. Hantavirus infection in East Asia. Comp Immunol Microbiol Infect Dis 2007;30: 341–56.
   PubMed Web of Science ®Google Scholar
• Vapalahti O, Mustonen J, Lundkvist A, Henttonen H, Plyusnin A, Vaheri A. Hantavirus infections in Europe. Lancet Infect Dis 2003;3:653–61.
   PubMed Web of Science ®Google Scholar
• Heyman PCC, Ducoffre G, Mailles A. Haemorrhagic fever with renal syndrome: An analysis of the outbreaks in Belgium, France, Germany, the Netherlands and Luxembourg in 2005. Eurosurveillance 2007;12:167–71.
   Google Scholar
• Winter CH, Brockmann SO, Piechotowski I, Alpers K, an der Heiden M, Koch J, . Survey and case-control study during epidemics of Puumala virus infection. Epidemiol Infect 2009;137:1479–85.
   PubMed Web of Science ®Google Scholar
• Tersago K, Verhagen R, Servais A, Heyman P, Ducoffre G, Leirs H. Hantavirus disease (nephropathia epidemica) in Belgium: Effects of tree seed production and climate. Epidemiol Infect 2009;137:250–6.
   PubMed Web of Science ®Google Scholar
• Olsson GE, Hjertqvist M, Lundkvist Å, Hörnfeldt B. Predicting high risk for human Hantavirus infections, Sweden. Emerg Infect Dis 2009;15:104–6.
   PubMed Web of Science ®Google Scholar
• Pettersson L, Klingstrom J, Hardestam J, Lundkvist A, Ahlm C, Evander M. Hantavirus RNA in saliva from patients with hemorrhagic fever with renal syndrome. Emerg Infect Dis 2008;14:406–11.
   PubMed Web of Science ®Google Scholar
• Pettersson L, Boman J, Juto P, Evander M, Ahlm C. Outbreak of Puumala virus infection, Sweden. Emerg Infect Dis 2008;5:808–10.
   Google Scholar
• Ahlm C, Thelin A, Elgh F, Juto P, Stiernström EL, Holmberg S, . Prevalence of antibodies specific to Puumala virus among farmers in Sweden. Scand J Work Environ Health 1998;24:104–8.
   PubMed Web of Science ®Google Scholar
• Settergren B. Clinical aspects of nephropathia epidemica (Puumala virus infection) in Europe: A review. Scand J Infect Dis 2000;32:125–32.
   PubMed Web of Science ®Google Scholar
• Hujakka H, Koistinen V, Eerikainen P, Kuronen I, Laatikainen A, Kauppinen J, . Comparison of a new immunochromatographic rapid test with a commercial EIA for the detection of Puumala virus specific IgM antibodies. J Clin Virol 2001; 23:79–85.
   PubMedGoogle Scholar
• Navarrete M, Barrera C, Zaror L, Otth C. Rapid immunochromatographic test for Hantavirus andes contrasted with capture-IgM ELISA for detection of Andes-specific IgM antibodies. J Med Virol 2007;79:41–4.
   PubMed Web of Science ®Google Scholar
• Ahlm C, Juto P, Stegmayr B, Settergren B, Wadell G, Tärnvik A, . Prevalence of serum antibodies to Hantaviruses in northern Sweden as measured by recombinant nucleocapsid proteins. Scand J Infect Dis 1997;29:349–54.
   PubMed Web of Science ®Google Scholar
• Settergren B, Juto P, Trollfors B, Wadell G, Norrby SR. Clinical characteristics of nephropathia epidemica in Sweden: Prospective study of 74 cases. Rev Infect Dis 1989;11:921–7.
   PubMedGoogle Scholar
• Cars O, Högberg LD, Murray M, Nordberg O, Sivaraman S, Lundborg CS, . Meeting the challenge of antibiotic resistance. BMJ 2008;337:a1438.
   PubMedGoogle Scholar
• Enne V. Reducing antimicrobial resistance in the community by restricting prescribing: Can it be done? J Antimicrob Chemother 2010;65:179–82.
   PubMedGoogle Scholar
• Arason VA, Sigurdsson JA. The problems of antibiotic overuse. Scand J Prim Health Care 2010;28:65–6.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Report on infectious diseases 2000: Overcoming antimicrobial resistance. Available at: http://www.who.int/infectious-disease-report/2000/index.html
   Google Scholar
• Arnold SR, Straus SE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev 2005(4):CD003539.
   PubMedGoogle Scholar
• Low D. Reducing antibiotic use in influenza: Challenges and rewards. Clin Microbiol Infect 2008;14:298–306.
   PubMed Web of Science ®Google Scholar
• McIsaac WJ, Moineddin R, Ross S. Validation of a decision aid to assist physicians in reducing unnecessary antibiotic drug use for acute cystitis. Arch Intern Med 2007;167:2201–6.
   PubMedGoogle Scholar
• Butler CC, Simpson S, Wood F. General practitioners’ perceptions of introducing near-patient testing for common infections into routine primary care: A qualitative study. Scand J Prim Health Care 2008;26:17–21.
   PubMed Web of Science ®Google Scholar
• Miettinen MH, Makela SM, Ala-Houhala IO, Huhtala HS, Koobi T, Vaheri AI, . Ten-year prognosis of Puumala Hantavirus-induced acute interstitial nephritis. Kidney Int 2006;69:2043–8.
   PubMed Web of Science ®Google Scholar
• Miettinen MH, Makela SM, Ala-Houhala IO, Huhtala HS, Koobi T, Vaheri AI, . Tubular proteinuria and glomerular filtration 6 years after puumala Hantavirus-induced acute interstitial nephritis. Nephron Clin Pract 2009;112:c115–20.
   PubMedGoogle Scholar
• Pergam SA, Schmidt DW, Nofchissey RA, Hunt WC, Harford AH, Goade DE. Potential renal sequelae in survivors of Hantavirus cardiopulmonary syndrome. Am J Trop Med Hyg 2009;80:279–85.
   PubMed Web of Science ®Google Scholar
• Sloane PD, MacFarquhar JK, Sickbert-Bennett E, Mitchell CM, Akers R, Weber DJ, . Syndromic surveillance for emerging infections in office practice using billing data. Ann Fam Med 2006;4:351–8.
   PubMedGoogle Scholar